Literature DB >> 20802409

Melatonin and childhood refractory epilepsy--a pilot study.

Justyna Paprocka1, Renata Dec, Ewa Jamroz, Elzbieta Marszał.   

Abstract

BACKGROUND: The aim of the study was to assess diurnal melatonin secretion in children with refractory epilepsy (N=74) as compared to children without epileptic seizures (N=37) and to compare melatonin secretion in children with focal and generalized refractory epilepsy. MATERIAL/
METHODS: In the study group 4 subgroups were defined: children with focal symptomatic epilepsy, focal cryptogenic epilepsy, generalized symptomatic epilepsy, and generalized cryptogenic epilepsy. Melatonin level was measured every 3 hours using the RIA method.
RESULTS: Analysis of diurnal melatonin secretion indicated a lower level of the hormone in patients with refractory epilepsy. The daily rhythm of melatonin secretion in the study group was maintained, with a peak shift of melatonin secretion especially visible in the subgroup with generalized symptomatic refractory epilepsy in the age group between 6 months and 3 years of age.
CONCLUSIONS: The hypothesis may be formed that a lowered level of melatonin in the study group in relation to the comparison group is the consequence of the natural course of epilepsy or is influenced by antiepileptic drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802409

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  7 in total

1.  Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study.

Authors:  Sejal V Jain; Paul S Horn; Narong Simakajornboon; Dean W Beebe; Katherine Holland; Anna W Byars; Tracy A Glauser
Journal:  Sleep Med       Date:  2015-01-21       Impact factor: 3.492

2.  Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene.

Authors:  Ewa Pronicka; Anna Weglewska-Jurkiewicz; Maciej Pronicki; Jolanta Sykut-Cegielska; Pawel Kowalski; Magdalena Pajdowska; Irena Jankowska; Katarzyna Kotulska; Piotr Kalicinski; Joanna Jakobkiewicz-Banecka; Grzegorz Wegrzyn
Journal:  Med Sci Monit       Date:  2011-04

3.  Clinical uses of melatonin in pediatrics.

Authors:  Emilio J Sánchez-Barceló; Maria D Mediavilla; Russel J Reiter
Journal:  Int J Pediatr       Date:  2011-06-16

4.  Melatonin in Epilepsy: A New Mathematical Model of Diurnal Secretion.

Authors:  Justyna Paprocka; Marek Kijonka; Marcin Pęcka; Maria Sokół
Journal:  Int J Endocrinol       Date:  2016-07-13       Impact factor: 3.257

5.  Melatonin in Tuberous Sclerosis Complex Analysis Using Modern Mathematical Modeling Methods.

Authors:  Justyna Paprocka; Marek Kijonka; Łukasz Boguszewicz; Maria Sokół
Journal:  Int J Endocrinol       Date:  2017-04-25       Impact factor: 3.257

6.  Investigating Potential Biomarkers in Autism Spectrum Disorder.

Authors:  Carolyn Bridgemohan; David M Cochran; Yamini J Howe; Katherine Pawlowski; Andrew W Zimmerman; George M Anderson; Roula Choueiri; Laura Sices; Karen J Miller; Monica Ultmann; Jessica Helt; Peter W Forbes; Laura Farfel; Stephanie J Brewster; Jean A Frazier; Ann M Neumeyer
Journal:  Front Integr Neurosci       Date:  2019-08-02

7.  Melatonin and Angelman Syndrome: Implications and Mathematical Model of Diurnal Secretion.

Authors:  Justyna Paprocka; Marek Kijonka; Piotr Wojcieszek; Marcin Pęcka; Ewa Emich-Widera; Maria Sokół
Journal:  Int J Endocrinol       Date:  2017-12-12       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.